SE8104625L - Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi - Google Patents

Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi

Info

Publication number: SE8104625L
Authority: SE; Sweden
Prior art keywords: inhibitors; therapy; aromatas; prophylax; application
Prior art date: 1981-05-22

Application number

SE8104625A

Other languages

Unknown language ( )

English (en)

Other versions

SE462639B (sv

Inventor

H-U Schweikert

U Tunn

T Senge

F Neumann

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-05-22

Filing date

1981-07-31

Publication date

1982-11-23

1981-07-31 Application filed by Schering Ag filed Critical Schering Ag

1982-11-23 Publication of SE8104625L publication Critical patent/SE8104625L/sv

1990-08-06 Publication of SE462639B publication Critical patent/SE462639B/sv

Links

238000002560 therapeutic procedure Methods 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title 1
210000002307 prostate Anatomy 0.000 title 1
239000003886 aromatase inhibitor Substances 0.000 abstract 3
229940122815 Aromatase inhibitor Drugs 0.000 abstract 2
206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
229940046844 aromatase inhibitors Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
BPEWUONYVDABNZ-DZBHQSCQSA-N testolactone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(OC(=O)CC4)[C@@H]4[C@@H]3CCC2=C1 BPEWUONYVDABNZ-DZBHQSCQSA-N 0.000 abstract 1
229960005353 testolactone Drugs 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

SE8104625A 1981-05-22 1981-07-31 Anvaending av aromatashaemmare foer framstaellning av laekemedel foer profylax och behandling av benign prostatahyperplasi SE462639B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19813121153 DE3121153A1 (de)	1981-05-22	1981-05-22	"verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"

Publications (2)

Publication Number	Publication Date
SE8104625L true SE8104625L (sv)	1982-11-23
SE462639B SE462639B (sv)	1990-08-06

Family

ID=6133383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8104625A SE462639B (sv)	1981-05-22	1981-07-31	Anvaending av aromatashaemmare foer framstaellning av laekemedel foer profylax och behandling av benign prostatahyperplasi

Country Status (13)

Country	Link
US (1)	US4596797A (sv)
JP (1)	JPS57193411A (sv)
AU (1)	AU563524B2 (sv)
BE (1)	BE890521A (sv)
CH (1)	CH648485A5 (sv)
DE (1)	DE3121153A1 (sv)
DK (1)	DK354781A (sv)
GB (1)	GB2100601B (sv)
IT (1)	IT1168028B (sv)
LU (1)	LU83544A1 (sv)
NL (1)	NL8103874A (sv)
SE (1)	SE462639B (sv)
ZA (1)	ZA823500B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3378208D1 (en) *	1982-12-21	1988-11-17	Ciba Geigy Ag	Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds
DE3323321A1 (de) *	1983-06-24	1985-01-03	Schering AG, 1000 Berlin und 4709 Bergkamen	Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
GB8531747D0 (en) *	1985-12-24	1986-02-05	Erba Farmitalia	10beta-alkynylestrene derivatives
GB8624251D0 (en) *	1986-10-09	1986-11-12	Erba Farmitalia	"1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
US5595985A (en)	1989-03-10	1997-01-21	Endorecherche Inc.	Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
WO1991000731A1 (en) *	1989-07-07	1991-01-24	Endorecherche Inc.	Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US5227375A (en) *	1990-02-08	1993-07-13	Endorecherche, Inc.	Aromatase inhibitors
US5519051A (en) *	1991-03-28	1996-05-21	Teikoku Hormone Mfg. Co., Ltd.	Oxa- or azasteroid derivatives
BR9916536A (pt)	1998-12-23	2002-01-02	Searle & Co	Método para o tratamento ou prevenção de um distúrbio de neoplasia em um mamìfero em necessidade deste tratamento ou prevenção, e, combinação
US6649645B1 (en)	1998-12-23	2003-11-18	Pharmacia Corporation	Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US7939517B2 (en) *	2004-07-21	2011-05-10	Kneller Bruce W	1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses
EP1854465A1 (en)	2006-05-12	2007-11-14	Alexander Tobias Teichmann	Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
US20080245375A1 (en) *	2007-04-05	2008-10-09	Medtronic Vascular, Inc.	Benign Prostatic Hyperplasia Treatments
ES2547339T3 (es) *	2007-11-13	2015-10-05	Curadis Gmbh	Esteroides C-19 para usos terapéuticos específicos
CA2794565C (en)	2010-04-08	2018-08-21	Emory University	Substituted androst-4-ene diones
US20160361380A1 (en)	2015-06-12	2016-12-15	Nymox Corporation	Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US10183058B2 (en)	2016-06-17	2019-01-22	Nymox Corporation	Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en)	2016-07-28	2019-01-08	Nymox Corporation	Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en)	2016-09-07	2020-01-14	Nymox Corporation	Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en)	2017-03-01	2019-07-02	Nymox Corporation	Compositions and methods for improving sexual function
EP3666276A1 (en)	2018-12-14	2020-06-17	dcic Biopharmaceutical Limited	Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3423507A (en) *	1966-02-25	1969-01-21	Schering Corp	Method of treating benign prostratic hypertrophy
US4055641A (en) *	1976-05-10	1977-10-25	Richardson-Merrell Inc.	Method of treating benign prostatic hypertrophy
DE2817157A1 (de) *	1978-04-17	1979-10-25	Schering Ag	Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
US4235893A (en) *	1978-05-08	1980-11-25	Brodie Angela M	Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
EP0100566B1 (en) *	1982-07-14	1986-02-19	Akzo N.V.	Novel 19-thio-androstane derivatives

1981
- 1981-05-22 DE DE19813121153 patent/DE3121153A1/de active Granted
- 1981-07-31 SE SE8104625A patent/SE462639B/sv not_active IP Right Cessation
- 1981-08-10 CH CH5142/81A patent/CH648485A5/de not_active IP Right Cessation
- 1981-08-10 DK DK354781A patent/DK354781A/da not_active Application Discontinuation
- 1981-08-11 LU LU83544A patent/LU83544A1/de unknown
- 1981-08-17 JP JP56127856A patent/JPS57193411A/ja active Granted
- 1981-08-19 NL NL8103874A patent/NL8103874A/nl not_active Application Discontinuation
- 1981-09-24 IT IT24117/81A patent/IT1168028B/it active
- 1981-09-28 BE BE0/206084A patent/BE890521A/fr not_active IP Right Cessation
1982
- 1982-05-10 GB GB08213404A patent/GB2100601B/en not_active Expired
- 1982-05-19 ZA ZA823500A patent/ZA823500B/xx unknown
- 1982-05-24 AU AU84074/82A patent/AU563524B2/en not_active Ceased
1985
- 1985-05-13 US US06/733,436 patent/US4596797A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK354781A (da)	1982-11-23
IT8124117A0 (it)	1981-09-24
LU83544A1 (de)	1981-12-01
CH648485A5 (de)	1985-03-29
JPH0150206B2 (sv)	1989-10-27
NL8103874A (nl)	1982-12-16
SE462639B (sv)	1990-08-06
AU563524B2 (en)	1987-07-16
JPS57193411A (en)	1982-11-27
AU8407482A (en)	1982-11-25
ZA823500B (en)	1983-03-30
US4596797A (en)	1986-06-24
GB2100601B (en)	1986-02-05
GB2100601A (en)	1983-01-06
BE890521A (fr)	1982-03-29
IT1168028B (it)	1987-05-20
DE3121153A1 (de)	1982-12-09
DE3121153C2 (sv)	1991-06-20

Similar Documents

Publication	Publication Date	Title
SE8104625L (sv)	1982-11-23	Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi
SE8104624L (sv)	1982-11-23	Anvendning av kombinationen av en aromatashemmare med ett antindrogent medel for profylax och terapi av prostatahyperaplasi
NO981392D0 (no)	1998-03-27	Substituerte pyrazolylbenzensulfonamider for anvendelse i veterinærterapi som antiinflammatorisk middel
ATE4168T1 (de)	1983-08-15	2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
FI925211A0 (fi)	1992-11-17	Isoxazol-4-karboxylsyraamider och hydroxialkylidencyanaettiksyraamider,laekemedel innehaollande dessa och anvaendning av dessa
NO893240D0 (no)	1989-08-11	Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
LV11894A (lv)	1997-12-20	Jauni hromana un tiohromana atvasinajumi
FI915093A0 (fi)	1991-10-29	Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
NO164219C (no)	1990-09-12	Fremgangsmaate og anlegg for behandling av returnert boreslam.
ATE38036T1 (de)	1988-11-15	Benzothiophenderivate als bronchodilatoren.
GR3029490T3 (en)	1999-05-28	Use of leflunomid for the inhibition of tumor necrosis factor alpha.
ATE69953T1 (de)	1991-12-15	Verwendung von polysulfatierten heparinen.
NO894222D0 (no)	1989-10-24	Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
NO972449L (no)	1997-07-22	Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
ES2058343T3 (es)	1994-11-01	Piridinas disubstituidas.
NO891703D0 (no)	1989-04-25	Farmasoeytiske sammensetninger for behandling av psoriasis.
NO922136L (no)	1992-05-29	Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
DE69305348T2 (de)	1997-02-20	Proteintyrosinphosphatase alpha - Inhibitoren zur Tumorbehandlung
EP0350738A3 (de)	1991-04-03	(S)-Emopamil zur Anwendung bei der Behandlung von Migräne
FI844645A0 (fi)	1984-11-27	1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DK225689A (da)	1989-05-08	Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
ES2089091T3 (es)	1996-10-01	Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.
SE7809880L (sv)	1980-03-21	Vaccin for profylax och behandling av clostridiosis hos djur och fjederfe
SU1274694A1 (ru)	1986-12-07	Способ лечени больных с заболевани ми неврогенного генеза
DE3879709D1 (de)	1993-04-29	Platin-arzneimittel.

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 8104625-2

Format of ref document f/p: F

1995-05-08

NUG

Patent has lapsed

Ref document number: 8104625-2

Format of ref document f/p: F

1996-05-13

NUG

Patent has lapsed

Ref document number: 8104625-2

Format of ref document f/p: F